US Home Healthcare Market Outlook 2020

北米の在宅医療市場動向

◆タイトル:US Home Healthcare Market Outlook 2020
◆商品コード:RNCOS5042110
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年4月
◆ページ数:70
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名使用)USD ⇒換算¥0見積依頼/購入/質問フォーム
Multi-User(全社内共有可)USD ⇒換算¥0見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"北米の在宅医療市場動向"について調査・分析し、種類別分析、市場規模及び予測、競争状況等の情報をお届けいたします。

US home healthcare industry has become one of the fastest growing sectors. An increasing number of aging population and government initiatives, shifted the expensive hospital care to the home. The prevalence of chronic diseases, growing physician acceptance of home healthcare, technological advancements and cost-effective treatment options from public and private payers have all fostered the industry growth. The home healthcare market is forecasted to grow at a CAGR of approximately 7% during 2015-2020.

In latest research study, “US Home Healthcare Market Outlook 2020”, RNCOS’ analysts have identified the market dynamics and clearly highlight the areas offering promising possibilities for companies to boost their growth. The growth of the market is driven by increasing federal and state funding by Medicare and Medicaid boosting the demand for healthcare services.

In the present report, the market has been studied on three major grounds – by services (unskilled nursing service, rehabilitation therapy, infusion therapy, respiratory therapy), by equipment (diagnostic and monitoring home devices, medical supplies, therapeutic home healthcare, mobility assist devices) and by telehealth. Further, the growth of all the segments have been analyzed with market projections till 2020.

The study also includes current market trends and drivers detailing the growth and the untapped potential of the market. Moreover, it delves into the present regulatory framework related to the industry. The report additionally provides an insight about the competitive landscape, which includes business overview, key financials and strengths and weaknesses of the top home healthcare players in the US. There’s also coverage of the detailed analysis of their top services in terms of revenue generation.

This report would help the clients to identify the driving force and opportunities existing in the market. In a nutshell, the research provides all the prerequisite information for intending clients looking out to venture in US home healthcare industry, and facilitate them to devise strategies while going for an investment/partnership in the market.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. Market Trends and Drivers
3.1 Technological Advancement Making Medical Devices a Viable Option for Home Healthcare
3.2 Aging Population Driving the Adoption of Home Healthcare
3.3 Rising Prevalence of Diseases Boosting the Demand for Therapy and Monitoring at Home
4. Home Healthcare Market Outlook to 2020
4.1 By Equipment
4.1.1 Diagnostic & Monitoring Devices
4.1.2 Therapeutics Devices
4.1.3 Medical Supplies
4.1.4 Mobility Assist Devices
4.2 By Services
4.2.1 Unskilled Nursing Services
4.2.2 Rehabilitation Therapy Services
4.2.3 Respiratory Therapy Services
4.2.4 Infusion Therapy Services
4.3 Telehealth
5. Regulatory Framework
6. Competitive Landscape
6.1 Lincare Holdings Inc.
6.1.1 Business Overview
6.1.2 Key Financials
6.1.3 Strength and Weakness Analysis
6.2 Kindred Healthcare Inc.
6.2.1 Business Overview
6.2.2 Key Financials
6.2.3 Strength and Weakness Analysis
6.3 Amedisys, Inc.
6.3.1 Business Overview
6.3.2 Key Financials
6.3.3 Strength and Weakness Analysis
6.4 Apria Health Group
6.4.1 Business Overview
6.4.2 Key Financials
6.4.3 Strength and Weakness Analysis:
6.5 Chemed Corporation
6.5.1 Business Overview
6.5.2 Key Financials
6.5.3 Strength and Weakness Analysis
6.6 National HealthCare Corporation
6.6.1 Business Overview
6.6.2 Key Financials
6.6.3 Strength and Weakness Analysis
6.7 LHC Group, Inc.
6.7.1 Business Overview
6.7.2 Key Financials
6.7.3 Strength and Weakness Analysis

List of Figures:

Figure 3-1: Per Day Cost (US$) – Hospital Vs Home or Alternate Site
Figure 4-1: Home Healthcare Market (Billion US$), 2014-2020
Figure 4-2: Home Healthcare Market by Segment (%), 2014
Figure 4-3: Home Healthcare Market by Player (%), 2014
Figure 4-4: Home Healthcare Market by Payor (%), 2012
Figure 4-5: Home Healthcare Equipment Market (Billion US$), 2014-2020
Figure 4-6: Home Healthcare Equipment Market by Type (%), 2014
Figure 4-7: Diagnostics and Monitoring Home Devices Market (Billion US$), 2014 & 2020
Figure 4-8: Therapeutics Home Devices Market (Billion US$), 2014 & 2020
Figure 4-9: Medical Supplies Market (Billion US$), 2014 & 2020
Figure 4-10: Mobility Assist Devices Market (Billion US$), 2014 & 2020
Figure 4-11: Home Healthcare Services Market (Billion US$), 2014-2020
Figure 4-12: Home Healthcare Services Market by Type (%), 2014
Figure 4-13: Unskilled Nursing Services Market (Billion US$), 2014 & 2020
Figure 4-14: Rehabilitation Therapy Services Market (Billion US$), 2014 & 2020
Figure 4-15: Respiratory Therapy Services Market (Billion US$), 2014 & 2020
Figure 4-16: Infusion Therapy Services Market (Billion US$), 2014 & 2020
Figure 4-17: Telehealth Market (Billion US$), 2014-2020
Figure 6-1: Lincare Holdings Inc. – Revenue by Segment (%), 2011
Figure 6-2: Lincare Holdings Inc. – Revenue by Payors (%), 2011
Figure 6-3: Kindred Healthcare Inc. – Revenue by Segment (%), 2014
Figure 6-4: Kindred Healthcare Inc- Care Management Revenue by Services (%), 2014
Figure 6-5: Kindred Healthcare Inc – Care Management Revenue by Payors (%), 2014
Figure 6-6: Amedisys, Inc – Revenue by Services (%), 2013
Figure 6-7: Amedisys, Inc – Revenue by Payors (%), 2013
Figure 6-8: Apria Health Group – Revenue by Services (%), 2012
Figure 6-9: Chemed Corporation – Revenue by Subsidiaries (%), 2013
Figure 6-10: Chemed Corporation (Subsidiary Vitas Healthcare Corporation) – Revenue by Services (%), 2013
Figure 6-11: Chemed Corporation (Subsidiary-Vitas Healthcare Corporation) – Revenue by Payors (%), 2013
Figure 6-12: National Healthcare Corporation – Revenue by Payors (%), 2013
Figure 6-13: LHC Group Inc. – Revenue by Segments (%), 2013
Figure 6-14: LHC Group Inc. – Revenue by Payors (%), 2013

List of Tables:

Table 4-1: Leading Manufacturers of Home Diagnostic and Monitoring devices
Table 4-2: Leading Manufacturers of Therapeutic Home Healthcare Devices
Table 4-3: Leading Manufacturers of Medical Supplies
Table 4-4: Leading Manufacturers of Mobility Assist Devices
Table 4-5: Leading Manufacturers of Home Infusion Devices
Table 6-1: Home Healthcare Market Penetration by Players
Table 6-2: Lincare Holdings Inc. – Financial Overview (Million US$), FY 2009-FY 2011
Table 6-3: Kindred Healthcare Inc. – Financial Overview (Million US$), FY 2012-FY 2014
Table 6-4: Amedisys, Inc – Financial Overview (Million US$), FY 2011-FY 2013
Table 6-5: Apria Health Group – Financial Overview (Million US$), FY 2010-FY 2012
Table 6-6: Chemed Corporation – Financial Overview (Million US$), FY 2011-FY 2013
Table 6-7: National Healthcare Corporation – Financial Overview (Million US$), FY 2011-FY 2013
Table 6-8: LHC Group Inc. – Financial Overview (Million US$), FY 2011-FY 2013



【レポートのキーワード】

在宅医療、北米

★調査レポート[北米の在宅医療市場動向] ( US Home Healthcare Market Outlook 2020 / RNCOS5042110) 販売に関する免責事項
[北米の在宅医療市場動向] ( US Home Healthcare Market Outlook 2020 / RNCOS5042110) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆